Alexandria Real Estate Equities
ARE
#2464
Rank
NZ$12.64 B
Marketcap
NZ$72.99
Share price
-3.14%
Change (1 day)
-41.83%
Change (1 year)
Alexandria Real Estate Equities, Inc. is a real estate investment trust that invests in office buildings and laboratories.

Earnings for Alexandria Real Estate Equities (ARE)

Earnings in 2025 (TTM): -NZ$1.71 Billion

According to Alexandria Real Estate Equities 's latest financial reports the company's current earnings are NZ$2.94 Billion. a decrease over its 2024 earnings that were of NZ$1.19 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Alexandria Real Estate Equities from 2013 to 2025

Annual earnings

Year Earnings Change
2025 -NZ$1.7 Billion-242.13%
2024 NZ$1.19 B96.11%
2023 NZ$0.60 B-53.56%
2022 NZ$1.31 B-3.96%
2021 NZ$1.36 B-20.26%
2020 NZ$1.71 B72.88%
2019 NZ$0.98 B3.11%
2018 NZ$0.95 B73.54%
2017 NZ$0.55 B464.88%
2016 NZ$97.9 M-77.32%
2015 NZ$0.43 B36.31%
2014 NZ$0.31 B-10.81%
2013 NZ$0.35 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
NZ$17.45 B-1,129.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$44.07 B-2,699.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$15.37 B-1,006.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
NZ$16.78 B-1,089.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
NZ$2.03 B-219.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$15.97 B-1,042.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
NZ$0.98 B-158.16%๐Ÿ‡บ๐Ÿ‡ธ USA